Skip to main content

Table 1 Patient characteristics in the two analysis populations

From: Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer

Characteristic EORTC QLQ-C30 FACT-G
N = 903 N = 908
Age (years) 68 (58–74) 68 (58–74)
Sex
 Male 489 (54.2) 489 (53.9)
 Female 414 (45.8) 419 (46.1)
Hospitalization
 Yes 186 (20.6) 180 (20.8)
 No 717 (79.4) 719 (79.2)
ECOG performance status
 0 451 (49.9) 447 (49.2)
 1 368 (40.8) 377 (41.5)
 2 63 (7.0) 64 (7.0)
 3 20 (2.2) 19 (2.1)
 Unknown (0, 1, 2, or 3) 1 (0.1) 1 (0.1)
Tumor type
 Lung cancer 317 (35.1) 312 (34.4)
 Stomach cancer 65 (7.2) 64 (7.0)
 Colorectal cancer 222 (24.6) 226 (24.9)
 Breast cancer 113 (12.5) 116 (12.8)
 Other solid tumors 186 (20.6) 190 (20.9)
Stage at diagnosis
 I 49 (5.4) 48 (5.3)
 II 70 (7.8) 70 (7.7)
 III 184 (20.4) 185 (20.4)
 IV 588 (65.1) 593 (65.3)
 Unknown 12 (1.3) 12 (1.3)
Site of metastasis or recurrencea
 None 77 (8.5) 81 (8.9)
 Liver 198 (21.9) 204 (22.5)
 Lung 285 (31.6) 280 (30.8)
 Bone 160 (17.7) 165 (18.2)
 Brain 98 (10.9) 98 (10.8)
 Lymph nodes 361 (40.0) 361 (39.8)
 Others 225 (24.9) 227 (25.0)
History of surgery
 Yes 480 (53.2) 483 (53.2)
 No 422 (46.7) 424 (46.7)
 Unknown 1 (0.1) 1 (0.1)
Type of treatmenta
 Chemotherapy 582 (64.5) 590 (65.0)
 Endocrine therapy 65 (7.2) 66 (7.3)
 Molecular targeted therapy 159 (17.6) 158 (17.4)
 Immunotherapy 108 (12.0) 104 (11.5)
 Palliative therapy 35 (3.9) 37 (4.1)
 Others 8 (0.9) 8 (0.9)
  1. Median (IQR) is reported for age, whereas number (%) is reported for other characteristics
  2. EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; FACT-G, Functional Assessment of Cancer Therapy General; ECOG, Eastern Cooperative Oncology Group
  3. aMultiple choices are allowed